Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

offering a valuable approach for target identification beyond the traditional protein-level focus. With the deepen research, various metabolomics-based methods emerged for better discovery, including ...

Further, this segment is classified into drug discovery target identification & validation lead identification & optimization de novo drug design. Some other major drivers for the drug discovery ...

Orphan drugs offer critical treatment options for rare diseases, improving quality of life for underserved patients and ...

Rancho BioSciences, the premier tech-enabled data science partner for biopharma, headquartered in San Diego, California, is ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

The convergence of AI, accelerated computing and biological data is turning healthcare into the largest technology industry. Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc ...

By leveraging this capability, AlphaMeld Corporation has successfully progressed several candidates from target identification ... This model has led to the discovery of novel targets which have now ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Rancho Biosciences will leverage its expertise in subject matter expert data processing and curation to prepare a wide range of life science datasets-including clinical, single cell, spatial, genomic, ...